Quote:

---

Potential Inflammatory Effects: Leronlimab's inhibition of CCR5 has been explored for conditions such as HIV, cancer, and autoimmune diseases, where the modulation of macrophage function and inflammatory responses could be beneficial or potentially harmful. In some cases, manipulating macrophage function can influence the disease outcome—both beneficially and negatively—depending on whether the inflammatory response is appropriately controlled.

---

Where AI fails is that it generalizes information rather than knowing and incorporating the specifics. Where leronlimab may not be appropriate is if there are genetic anomalies where the expression of the other CCR receptors are compromised, similar to the CCR5 delta 32 deletion.